A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2021-09-20
Target enrollment:
Participant gender:
Summary
This is a study in minors (7 to 17 years old) diagnosed with generalized anxiety disorder
(GAD) and evaluated using standard questionnaires as having at least moderate severity of
GAD. Participating minors will be assigned to receive either the study drug escitalopram or a
pill without any drug in it called a placebo. The purpose of this research is to study the
safety and effectiveness of escitalopram in minors with GAD.